Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells

Molecular Endocrinology

Volumn 17, Issue 1, 2003, Pages 56-66

  Zhou, Shuanhu ^a   Turgeman, Gadi ^a   Harris, Stephen E ^c   Leitman, Dale C ^b   Komm, Barry S ^d   Bodine, Peter V N ^d   Gazit, Dan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; MESSENGER RNA; PHYTOESTROGEN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO; ESTROGEN THERAPY; FEMALE; GENETIC TRANSCRIPTION; MESENCHYME; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GENISTEIN; MESODERM; MICE; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; STEM CELLS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; EUKARYOTA;

EID: 0037249209     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0210     Document Type: Article

References (68)

1. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz R, Hewick R, Wang EA 1988 Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534
2. Wang EA, Rosen V, D'Alessandro JS, Bandy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, Lapan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM 1990 Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220-2224
3. Gazit D, Turgeman G, Kelley P, Wang E, Jalenak M, Zilberman Y, Moutsatsos I 1999 Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell mediated gene therapy. J Gene Med 1:121-133
4. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T 1990 The non-osteogenic mouse pluripotent cell line C3H10T1/2 is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172:295-299
5. Theis RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V 1992 Recombinant bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324
6. Wang EA, Israel DI, Kelly S, Luxenberg DP 1993 human bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9:57-71
7. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Ketagiri T, Wozney JM, Rosen V, Yoshiki S 1996 Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220:366-371
8. Feng JQ, Chen D, Ghosh-Choudhury N, Esparza J, Mundy GR, Harris SE 1997 Bone morphogenetic protein 2 transcripts in rapidly developing deer antler tissue contain an extended 5′ non-coding region arising from a distal promoter. Biochim Biophys Acta 1350:47-52
9. Hanada K, Dennis JE, Caplan AJ 1997 Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow derived mesenchymal stem cells. J Bone Miner Res 12:1606-1614
10. Moutsatsos IK, Turgeman G, Zhou S, Kurkalli BG, Pelled G, Tzur L, Kelley P, Stumm N, Mi S, Mueller R, Zilberman Y, Gazit D 2001 Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3:449-461
11. Turgeman G, Pittman D, Muller R, Kurkalli BG, Zhou S, Pelled G, Peyser A, Zilberman Y, Moutsatsos I, Gazit D 2001 Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3:240-251
12. Lyons KM, Pelton RW, Hogan BIM 1990 Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP2A). Development 109:833-844
13. Hogan BLM 1996 Bone mophogenetic proteins in development. Curr Opin Genet Dev 6:432-438
14. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR1994 Expression of transforming growth factor β on bone nodule formation and expression of bone morphogentic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:389-394
15. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT 2002 Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101-110
16. Huang W, Rudkin GH, Carlsen B, IshidaK, Ghasri P, Anvar B, Yamaguchi DT, Miller TA 2002 Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells. Exp Cell Res 274:226-234
17. Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO 2002 Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 292:144-152
18. Harris, SE, Mundy, GM, Ghosh-Choudhury N, Feng JQ 2000 Methods and compositions for identifying osteogenic agents. U.S. patent 6,083,690
19. Helvering LM, Sharp RL, Ou X, Geiser AG 2000 Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 256:123-138
20. Carson-Jurica MA, Schrader WT, O'Malley BW 1990 Steroid receptor family: structure and functions. Endocr Rev 11:201-220
21. Beato M, Herrlich P, Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 58:851-857
22. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 15:275-300
23. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL 1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86
24. Ohashi T, Kusuhara S 1993 Immunoelectron microscopic detection of estrogen target cells in the bone marrow of estrogen-treated male Japanese quail. Bone Miner 20:31-39
25. Windahl SH, Norgard M, Kuiper GGJM, Gustafsson J-A, Andersson G 2000 Cellular distribution of estrogen receptor β in neonatal rat bone. Bone 26:117-121
26. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science 277:1508-1510
27. An J, Ribeiro RJ, Webb P, Gustafsson J-A, Kushner PJ, Baxter JD, Leitman DC 1999 Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 96:15161-15166
28. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC 2001 Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276:17808-17814
29. Tobias JH, Compston JE 1999 Does estrogen stimulate osteoblast function in postmenopausal women? Bone 24:121-124
30. Bain SD, Bailey MC, Celino DL, Lantry MM, Edwards MW 1993 High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. J Bone Miner Res 8:435-442
31. Chow J, Lean JM, Chambers TJ 1992 17 β-estradiol stimulates cancellous bone formation in female rats. Endocrinology 130:3025-3032
32. Chow J, Tobias JH, Colston KW, Chambers TJ 1992 Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89:74-78
33. Takano-Yamamoto T, Rodan GA 1990 Direct effects of 17 β-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87:2172-2176
34. Samuels A, Perry MJ, Tobias JH 1999 High-dose estrogen induces de novo medullary bone formation in female mice. J Bone Miner Res 14:178-186
35. Zhou H, Shen V, Dempster DW, Lindsay R 2001 Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 16:1300-1307
36. Turner RT 1999 Mice, estrogen, and postmenopausal osteoporosis. J Bone Miner Res 14:187-191
37. Zhou S, Zilberman Y, Wasserman K, Bain S, Sadovsky Y, Gazit D 2001 Estrogen modulates Estrogen receptor α and β expression, osteogenic activity and apoptosis in marrow stromal cells (MSCs) of osteoporotic mice. J Cell Biochem 81 (S36):144-155
38. Mathieu E, Merregaert J 1994 Characterization of the stromal osteogenic cell line MN7: mRNA steady-state level of selected osteogenic markers depends on cell density and is influenced by 17 β-estradiol. J Bone Miner Res 9:183-192
39. Turgeman G, Zilberman Y, Zhou S, Kelly P, Moutsatsos IK, Kharode YP, Borella LE, Bex FJ, Komm BS, Bodine PVN, Gazit D 2002 Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem 86:461-474
40. Hauguel de Mouzon S, Kahn CR 1991 Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells. Mol Endocrinol 5:51-60
41. Hall JM, McDonnell DP 1999 The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity is a key regulator of the cellular response to estrogen and antiestrogens. Endocrinology 140:5566-5578
42. Notelovitz M 1997 Estrogen therapy and osteoporosis: principles & practice. Am J Med Sci 313:2-12
43. Rodriguez JP, Garat S, Gajardo H, Pino AM, Seitz G 1999 Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem 75:414-423
44. van den Wijngaard A, Mulder WR, Dijkema R, Boersma CJ, Mosselman S, van Zoelen EJ, Olijve W 2000 Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells. Mol Endocrinol 14:623-633
45. Wang EA 1993 Bone morphogenetic proteins (BMPs): therapeutic potential in healing bone defects. Trends Biotechnol 11:379-383
46. Wozney JM, Rosen V 1998 Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 346:26-37
47. Erickson DM, Harris SE, Dean DD, Harris MA, Wozney JM, Boyan BD, Schwartz Z 1997 Recombinant bone Morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner. J Orthop Res 15:371-380
48. Driscol MD, Sathya G, Muyan M, Klinge CM, Hilf R, Bambara RA 1998 Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem 273:29321-29330
49. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson J-A, Safe S 2000 Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387
50. Webb P, Lopez G, Uht R, Kushner P 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
51. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P 2000 Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
52. Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R, Webb P, Greene G 2000 Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 230:20-26; discussion 27-40
53. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ 1999 The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13:1672-1685
54. Dubik D, Shiu RP 1992 Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594
55. Krishnan V, Wang X, Safe S 1994 Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269:15912-15917
56. Mueller MD, Vigne J-L, Minchenko A, Lebovic DI, Leitman DC, Taylor RN 2000 Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 97:10972-10977
57. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR 1994 raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63-69
58. Sato M, Rippy MK, Bryant HU 1996 Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J 10:905-912
59. Yang NN, Bryant HU, Hardikar S, Sato M, Galvin RJ, Glasebrook AL, Termine JD 1996 Estrogen and raloxifene stimulate transforming growth factor-β 3 gene expression in rat bone: a potential mechanism for estrogenor raloxifene-mediated bone maintenance. Endocrinology 137:2075-2084
60. Yang NN, Venugopalan M, Hardikar S, Glasebrook A 1996 Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:1222-1225
61. Clemett D, Spencer CM 2000 Raloxifene: a review of its use in postmenopausal osteoporosis. Drugs. 60:379-411
62. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH 1996 The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8:274-281
63. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T 2000 Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852
64. Messina M, Messina V 2002 Soyfoods, soybean isoflavones, and bone health: a brief overview. J Ren Nutr 10:63-68
65. Webb, P, Nguyen P, Shinsako J, Anderson C, Feng W, Nguyen MP, Chen D, Huang SM, Subramanian S, McKinerney E, Katzenellenbogen BS, Stallcup MR, Kushner PJ 1998 Estrogen receptor activation function1 works by binding p160 coactivator proteins. Mol Endocrinol 12:1605-1618
66. Gazit D, Zilberman Y, Turgeman G, Zhou S, Kahn A 1999 Recombinant TGF-β1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice. J Cell Biochem 73:379-389
67. Orly J, Rei Z, Greenberg NM, Richards JS 1994 Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa cell differentiation: use of reverse transcriptase-polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology 134:2336-2346
68. Guswami PC, Albee LD, Spitz DR, Ridnour LA 1997 A polymerase chain reaction assay for simultaneous detection and quantitation of proto-oncogene and GAPD mRNA in different cell growth rates. Cell Prolif 30:271-282